P520: POINT OF CARE CD19 CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELLS FOR RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA (AML) WITH ABERRANT CD19 ANTIGEN EXPRESSION
Ivetta Danylesko,
Noga Shem-Tov,
Ronit Yerushalmi,
Elad Jacoby,
Amos Toren,
Orit Itzhaki,
Roni Shouval,
Avichai Shimoni,
Avigdor Abraham,
Arnon Nagler
Affiliations
Ivetta Danylesko
1 Sheba Medical Center, Division of Hematology and Bone Marrow Transplantation, Ramat Gan, Israel
Noga Shem-Tov
1 Sheba Medical Center, Division of Hematology and Bone Marrow Transplantation, Ramat Gan, Israel
Ronit Yerushalmi
1 Sheba Medical Center, Division of Hematology and Bone Marrow Transplantation, Ramat Gan, Israel
Elad Jacoby
2 Tel Aviv University, Sackler Faculty of Medicine, Tel Aviv-Yafo, Israel
Amos Toren
2 Tel Aviv University, Sackler Faculty of Medicine, Tel Aviv-Yafo, Israel
Orit Itzhaki
2 Tel Aviv University, Sackler Faculty of Medicine, Tel Aviv-Yafo, Israel
Roni Shouval
1 Sheba Medical Center, Division of Hematology and Bone Marrow Transplantation, Ramat Gan, Israel
Avichai Shimoni
1 Sheba Medical Center, Division of Hematology and Bone Marrow Transplantation, Ramat Gan, Israel
Avigdor Abraham
1 Sheba Medical Center, Division of Hematology and Bone Marrow Transplantation, Ramat Gan, Israel
Arnon Nagler
1 Sheba Medical Center, Division of Hematology and Bone Marrow Transplantation, Ramat Gan, Israel
